Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)

China flag China · Delayed Price · Currency is CNY
8.12
-0.18 (-2.17%)
Jun 18, 2026, 3:00 PM CST
Market Cap6.70B -3.2%
Revenue (ttm)794.80M -0.8%
Net Income108.03M -49.4%
EPS0.13 -47.2%
Shares Out 825.10M
PE Ratio60.47
Forward PEn/a
Dividend0.06 (0.79%)
Ex-Dividend DateJul 17, 2025
Volume7,553,556
Open8.27
Previous Close8.30
Day's Range8.12 - 8.42
52-Week Range8.12 - 12.51
Beta-0.21
AnalystsStrong Buy
Price Target11.00 (+35.47%)
Earnings DateAug 24, 2026

About SHA:603229

Zhejiang Ausun Pharmaceutical Co., Ltd. engages in the research and development, process development, manufacture, and sale of APIs and pharmaceutical intermediates. It offers fluorine products, prostaglandins, antimicrobials, and oncology products. The company also provides products for liver disease, respiratory system, and cardiac and cerebral vessels, as well as CNS indications. In addition, it offers development and manufacturing services to the pharmaceutical, cosmetics, and nutritional industries. The company was founded in 2010 and is b... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 1,328
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603229
Full Company Profile

Financial Performance

In 2025, SHA:603229's revenue was 792.76 million, a decrease of -0.32% compared to the previous year's 795.29 million. Earnings were 130.57 million, a decrease of -36.86%.

Financial Statements